GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » Goodwill-to-Asset

G.Barekat Pharm (XTEH:BRKT1) Goodwill-to-Asset : 0.01 (As of Mar. 2017)


View and export this data going back to 2017. Start your Free Trial

What is G.Barekat Pharm Goodwill-to-Asset?

Goodwill to Asset ratio measures how much goodwill a company is recording compared to the total level of its assets. G.Barekat Pharm's Goodwill for the quarter that ended in Mar. 2017 was IRR380,992 Mil. G.Barekat Pharm's Total Assets for the quarter that ended in Mar. 2017 was IRR34,818,314 Mil. Therefore, G.Barekat Pharm's Goodwill to Asset Ratio for the quarter that ended in Mar. 2017 was 0.01.


G.Barekat Pharm Goodwill-to-Asset Historical Data

The historical data trend for G.Barekat Pharm's Goodwill-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G.Barekat Pharm Goodwill-to-Asset Chart

G.Barekat Pharm Annual Data
Trend Mar16 Mar17
Goodwill-to-Asset
- 0.01

G.Barekat Pharm Semi-Annual Data
Mar16 Mar17
Goodwill-to-Asset - 0.01

Competitive Comparison of G.Barekat Pharm's Goodwill-to-Asset

For the Biotechnology subindustry, G.Barekat Pharm's Goodwill-to-Asset, along with its competitors' market caps and Goodwill-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


G.Barekat Pharm's Goodwill-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, G.Barekat Pharm's Goodwill-to-Asset distribution charts can be found below:

* The bar in red indicates where G.Barekat Pharm's Goodwill-to-Asset falls into.



G.Barekat Pharm Goodwill-to-Asset Calculation

Goodwill to Asset ratio measures how much goodwill a company is recording compared to the total level of its assets.

It is calculated by dividing goodwill by total assets.

G.Barekat Pharm's Goodwill to Asset Ratio for the fiscal year that ended in Mar. 2017 is calculated as

Goodwill to Asset (A: Mar. 2017 )=Goodwill/Total Assets
=380992/34818314
=0.01

G.Barekat Pharm's Goodwill to Asset Ratio for the quarter that ended in Mar. 2017 is calculated as

Goodwill to Asset (Q: Mar. 2017 )=Goodwill/Total Assets
=380992/34818314
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


G.Barekat Pharm  (XTEH:BRKT1) Goodwill-to-Asset Explanation

If the goodwill-to-asset ratio increases, it can mean that the company is recording a proportionately higher amount of goodwill, assuming total assets are remaining constant. It is generally good to see a company increasing its assets regularly; however, if these increases are coming from intangible assets, such as goodwill, the increases may not be as good.

Increases in the goodwill-to-asset ratio might suggest that a company has been aggressively acquiring other firms or has seen its tangible assets decrease in value. When a large portion of total assets are attributable to intangible assets (such as goodwill), the company may be at risk of having that portion of its asset base wiped out quickly if it must record any goodwill impairments. Decreases in the goodwill-to-assets ratio suggest that the company has either written down some goodwill or increased its tangible assets.

Asset needs vary from industry to industry. This is why comparing goodwill-to-assets ratios is generally most meaningful among companies within the same industry. By comparing a company's goodwill to assets ratio to those of other companies within the same industry, investors can get a feel for how a company is managing its goodwill.


G.Barekat Pharm Goodwill-to-Asset Related Terms

Thank you for viewing the detailed overview of G.Barekat Pharm's Goodwill-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


G.Barekat Pharm (XTEH:BRKT1) Business Description

Traded in Other Exchanges
N/A
Address
No. 11, 5th Alley, Bucharest Avenue, Argentina Square, Tehran, IRN
G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.

G.Barekat Pharm (XTEH:BRKT1) Headlines

No Headlines